Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue

Poupon, Renée E., Balkau, Beverley, Guéchot, Jérôme, Heintzmann, François · 1994 · Hepatology

Abstract

The aim of this study was to define factors predictive of the onset of the terminal phase, defined by hyperbilirubinemia or the occurrence of a severe clinical complication, in patients with primary biliary cirrhosis treated with ursodeoxycholic acid. The 97 primary biliary cirrhosis patients in this study participated in a 2-yr clinical trial. Four of the 49 patients treated with ursodeoxycholic acid (13 to 15 mg/kg/day) entered the terminal phase of the disease, compared with 9 of the 48 patients assigned to placebo. In addition to clinical, conventional biological and histological parameters, we analyzed three serum markers of connective tissue components--type III procollagen aminoterminal peptide, hyaluronic acid and laminin. In the ursodeoxycholic acid-treated group, hyaluronic acid, type III procollagen aminoterminal peptide, bilirubin and splenomegaly were the factors most closely associated with entry into the terminal phase of the disease. In multivariate analysis, after adjustment for age, the hyaluronic acid level was the only predictive factor. In the placebo-treated group, the bilirubin level, total bile acid level, Mayo score, type III procollagen aminoterminal peptide, hyaluronic acid, splenomegaly and pruritus were associated with aggravation of disease. In multivariate analysis, high bilirubin level, high type III procollagen aminoterminal peptide or hyaluronic acid levels and low prothrombin time independently implied poor prognosis. In conclusion, when pat…

Overview

Integrity signals

Registry

Crossref · 10.1002/hep.1840190314

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 31 · Cited by 58

Research works printed but not linked: 5

  1. Poupon, 1992, Hepatology, 16, 91
  2. Plebani, 1991, Clin Chem, 24, 219
  3. Cox, 1972, J R Stat Soc B, 34, 187
  4. The PHGLM procedure. SUGI Supplemental Library User's Guide, version 5. Cary, NC: SAS Institut. Inc., 1986.
  5. BMDP statistical software. Los Angeles: University of California Press, 1990.

Metadata

Authors
Poupon, R. E., Balkau, B., Guéchot, J., & Heintzmann, F.
Affiliations
Inserm (FR)
Venue
Hepatology
Published
1994-03
Volume
19
Issue
3
Pages
635-640
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2039586762
Cited by
58
References
31
Citations by year
2025: 1 · 2023: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 3
FWCI
3.50
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 7854 d)
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
primary biliary cirrhosis, ursodeoxycholic acid, hyaluronic acid, laminin, hyperbilirubinemia, splenomegaly, prognosis
MeSH terms
Adult, Aged, Connective Tissue, Female, Forecasting, Humans, Hyperbilirubinemia, Liver Cirrhosis, Biliary, Male, Middle Aged, Placebos, Ursodeoxycholic Acid, Biomarkers, Multivariate Analysis, Survival Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. https://app.cochat.ai/papers/10.1002/hep.1840190314
The paper
Poupon, R. E., Balkau, B., Guéchot, J., & Heintzmann, F. (1994). Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. Hepatology. https://doi.org/10.1002/hep.1840190314

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.